Bilirubin nanoparticles ameliorate allergic lung inflammation in a mouse model of asthma
Source abstract
Abstract
Although asthma, a chronic inflammatory airway disease, is relatively well-managed by inhaled corticosteroids, the side effects associated with the long-term use of these agents precipitate the need for alternative therapeutic options based on differing modes of action. Bilirubin, a potent endogenous antioxidant, and anti-inflammatory molecule have been shown to ameliorate asthmatic symptoms; however, its clinical translation has been limited owing to its water insolubility and associated potential toxicity. Here we report the first application of bilirubin-based nanoparticles (BRNPs) as a nanomedicine for the treatment of allergic lung inflammatory disease. BRNPs were prepared directly from self-assembly of PEGylated bilirubin in aqueous solution and had a hydrodynamic diameter of ∼100 nm. Because allergen-specific type 2 T-helper (Th2) cells play a key role in the pathogenesis and progression of allergic asthma, the effects of BRNPs on Th2 immune responses were investigated both in vivo and in vitro. BRNPs after intravenous injection (i.v.) showed much higher serum concentration and a longer circulation time of bilirubin than the intraperitoneal injection (i.p.) of BRNPs or unconjugated bilirubin (UCB). The anti-asthmatic effects of BRNPs were assessed in a mouse model of allergen-induced asthma. Compared with UCB, treatment with BRNPs suppressed the symptoms of experimental allergic asthma and dramatically ameliorated Th2-related allergic lung inflammation. Consistent with these results, BRNPs caused a reduction of Th2 cell populations and the expression of related cytokines by antibody-stimulated CD4+ T cells in vitro. Therefore, our results establish BRNPs as an important immunomodulatory agent that may be useful as a therapeutic for allergic lung inflammatory disease and other immune-mediated disorders.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Heme Oxygenase-1 and Carbon Monoxide · Neonatal Health and Biochemistry · Asthma and respiratory diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (27)
Show source-provided references
1. Asthma10.1056/NEJM200102013440507 ↗
2. Allergic diseases and asthma: a global public health concern and a call to action10.1186/1939-4551-7-12 ↗
3. Transient relief of asthma symptoms during jaundice: a possible beneficial role of bilirubin10.1620/tjem.199.193 ↗
4. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration10.4049/jimmunol.174.6.3709 ↗
5. Bilirubin is an antioxidant of possible physiological importance10.1126/science.3029864 ↗
6. Immunomodulatory and immunotoxic effects of bilirubin: molecular mechanisms10.1189/jlb.0211070 ↗
7. The molecular basis for the immunomodulatory activities of unconjugated bilirubin10.1016/j.biocel.2013.09.014 ↗
8. Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis10.4049/jimmunol.181.3.1887 ↗
9. Bilirubin-induced neurologic damage–mechanisms and management approaches10.1056/NEJMra1308124 ↗
10. Bilirubin nanoparticles as a nanomedicine for anti-inflammation therapy10.1002/anie.201602525 ↗
11. Bilirubin toxicity to human erythrocytes: a review10.1016/j.cca.2006.06.012 ↗
12. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease10.4049/jimmunol.169.10.5904 ↗
13. Macelignan attenuated allergic lung inflammation and airway hyper-responsiveness in murine experimental asthma10.1016/j.lfs.2013.04.010 ↗
14. Designed nanocage displaying ligand-specific Peptide bunches for high affinity and biological activity10.1021/nn403184u ↗
15. Enhanced Th2 cell differentiation and function in the absence of Nox210.1111/all.12944 ↗
16. Immunologic influences on allergy and the TH1/TH2 balance10.1016/j.jaci.2003.11.025 ↗
17. The immunology of asthma10.1038/ni.3049 ↗
18. Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity10.1038/ni.2182 ↗
19. Selective modulation of T cell memory markers CD62L and CD44 on murine draining lymph node cells following allergen and irritant treatment10.1006/taap.1997.8218 ↗
20. The IL-33/ST2 pathway: therapeutic target and novel biomarker10.1038/nrd2660 ↗
21. Beyond oxidative stress: an immunologist's guide to reactive oxygen species10.1038/nri3423 ↗
22. Reactive oxygen species in inflammation and tissue injury10.1089/ars.2012.5149 ↗
23. Inhibition of airway inflammation and hyperreactivity by an antioxidant mimetic10.1016/S0891-5849(02)00919-X ↗
24. Nanoincorporation of curcumin in polymerglycerosomes and evaluation of their in vitro-in vivo suitability as pulmonary delivery systems10.1039/C5RA24032H ↗
25. Inhalable polymer-glycerosomes as safe and effective carriers for rifampicin delivery to the lungs10.1016/j.colsurfb.2016.03.044 ↗
26. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis10.1111/j.1365-2249.2010.04143.x ↗
27. Effector T cells in rheumatoid arthritis: lessons from animal models10.1016/j.febslet.2011.04.034 ↗